Heart in the hands of the doctor.

Relentless. Passionate. Focused.

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating autoinflammatory and autoimmune diseases with significant unmet medical need.





Our Story

Kiniksa has an experienced team with a track record delivering therapies to patients. We are currently advancing a portfolio of product candidates focused on autoinflammatory and autoimmune diseases.

Scientist looking into microscope

Our Strategy

Identify and rapidly develop a pipeline of product candidates with validated mechanisms of action, strong biologic rationale, and specific molecular potential.

PatientFocus

ClearBiology

Rare/SpecialtyDiseases

RapidDevelopment

GlobalVision

Our Mission

We are relentless and focused on putting patients at the center of everything we do and strive to develop life-changing medicines.

4

clinical stage
molecules

1

pivotal study in a rare debilitating disease

1

preclinical stage
molecule

3+

discovery stage
targets

100+

employees committed to helping patients